ImageWare Systems, Inc. (OTCMKTS:IWSY) Attempts to Recover Losses

ImageWare Systems, Inc. (OTCMKTS:IWSY) is trying to recover the losses of the last few days, after three days of active selling. IWSY easily reached heights of nearly $2.70, but stalled there, moving up and down around that price, still refusing to fizzle out. The ticker added a cautious 2% on Monday to $2.35 on buying volumes of around $600,000.

The current levels for IWSY are a two-year peak, and this means a larger correction may be justified as the ticker takes a breath after a ride fueled by sudden interest and high volumes. Despite the lack of a visible promotional effort, IWSY moved in among the most heavily traded OTC stocks, with a promising future in biometric technologies.

The shakiness of the past week may be attributed to the slowdown of press releases, with no news since the end of June. Still, inertia is keeping up the levels for IWSY, and any news on a contract or potential profitability may be welcomed. IWSY is still struggling to break through the high cost of developing and introducing the biometric recognition products.

The comments around IWSY concern the quality of investors, which may be attracted by the company’s solid record and good outlook.

The graph for IWSY recalls that of Vapor Corp. (OTCMKTS:VPCO), a company supplying e-cigarettes. This ticker also attracts with the possibility for longer-term potential, as well as the company’s good reserves of cash gained from an active worldwide distribution of a sought-after product.

AP Pharma, Inc. (OTCBB:APPA) is a similar bet, with longer-term possibilities, yet pressured by debt and losses, like many drug developers. The company trades around 45 cents, always responsive to good news.

In the case of IWSY, longer-term promises hardly indicate the next few days, which may come with surprising corrections. So it is best to estimate your own preferred time horizon and affordable investment before taking up this ticker.